Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive diagnostics tool. The evolution of BOS over time will be monitored using nmon-rigid image registration methods.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HRCT scans | Experimental | HRCT scan will be taken |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High Resolution Computed Tomography scans | Radiation | A HRCT scan at Functional Residual Capacity (FRC) and Total Lung Capacity (TLC) will be taken on visit 1, visit 2, visit 3, visit 4 and visit 5. An Upper Airway (UA) scan will be taken on visit 1. |
| Measure | Description | Time Frame |
|---|---|---|
| Airway Volume (iVaw) using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Airway Resistance (iRaw) using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Specific Airway Volume (siVaw) using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Specific Airway Resistance (siRaw) using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Lobe Volumes (iVlobes) using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Air Trapping using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Internal Lobar Airflow Distribution using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Low attenuation or Emphysema Score using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wilfried De Backer, M.D., M.S. | University Hospital of Antwerp | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Antwerp University Hospital | Edegem | Antwerp | 2650 | Belgium |
Not provided
| ID | Term |
|---|---|
| D001989 | Bronchiolitis Obliterans |
| D000092122 | Bronchiolitis Obliterans Syndrome |
| ID | Term |
|---|---|
| D001988 | Bronchiolitis |
| D001991 | Bronchitis |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 12 months |
| Blood Vessel Density or Fibrosis Score using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| Airway Wall Thickness using FRI | Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5. | 12 months |
| D008173 |
| Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D000092124 | Organizing Pneumonia |
| D006086 | Graft vs Host Disease |
| D007154 | Immune System Diseases |